New research suggests that intravenous vitamin C could be an excellent complementary therapy for breast cancer patients.
Breast cancer is the most common cancer in women, with more than 2 million cases each year.
Researchers from the University of Perugia in Italy recently reviewed research into the effectiveness of high-dose IV vitamin C, both in enhancing the efficacy of anti-cancer therapies and in decreasing their side effects.
At PIM we have a particular interest in intravenous nutrient therapies. Contact us to learn more.